Home MarketThyrocare Technologies Ltd.

Thyrocare Technologies Ltd. Stock Info: As on 2018-05-24 15:49:22

Nse

597.75

-0.15(-0.03%)
Change%
52 Week Range
565.50
7.00
871.00
10.00
Open605.00
Day's Range478.32 - 717.48
Value Traded (in ₹ Cr.) 0.76

Bse

605.00

6.65(1.11%)
Change %
52 Week Range
570.00
8.00
772.95
3.00
Open603.45
Day's Range478.68 - 718.02
Value Traded (in ₹ Cr.) 0.05

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 34,361,745.00 63.96%
Mutual Funds/UTI 10,051,979.00 18.71%
FII 5,227,886.00 9.73%
Employee 0.00 0.00%
Public 2,238,293.00 4.17%
Government 0.00 0.00%
Others 1,513,999.00 2.82%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 12.81
Basic EPS (Rs.) 13.93
Cash EPS 16.11
BVPerShare Excl 78.26
Operating Revenue 55.85
PBDITPerShare 23.26
Dividend 10.00
NPPerShare 13.93
Current Ratio 10.38
Quick Ratio 9.43
PriceToBV 9.15
Earnings 0.01
PBDIT Margin 41.65
PBT Margin 37.75
NP Margin 24.94
Return On Assets 16.79
Retention Ratios 64.10
Parameter Mar-17 (₹ Cr.) Yoy%change
Total Income 308.14
Total Expenses 194.84
EBITDA 124.99
PBT 113.30
PAT 74.85
Net Income 74.85
More
Parameter Mar-18 (₹ Cr.) 6M % change
Total Income 183.53
Total Expenses 105.09
EBITDA 72.02
PBT 78.22
PAT 49.41
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-17 (₹ Cr.) Yoy%change
Total share capital 53.72
Net worth 420.44
Investments 296.16
Total Liability 445.54
Total debt 0.00
Net block 91.33
Total Assets 445.54
Parameter Mar-17 (₹ Cr.) 6M % change
Total share capital 50.54
Net worth 278.92
Investments 162.46
Total Liability 294.37
Total debt 0.00
Net block 89.99
Total Assets 294.37
Company Curr Price Prev. Close Change% W's Low/High

Apollo Hospitals Enterprise Ltd.

966.55 963.95 0.27
9571038

Aster DM Healthcare Ltd.

179.6 177 1.47
175.95190.6

Dr. Lal Pathlabs Ltd.

890.05 882.5 0.86
851.25899

Fortis Healthcare Ltd.

142.95 144.9 -1.35
143.25152.9

Healthcare Global Enterprises Ltd.

304.25 302.8 0.48
300314

Indraprastha Medical Corporation Ltd.

45.75 45.4 0.77
4547.75

Kovai Medical Center and Hospital Ltd.

641.65 624.85 2.68
629.9649.9
Company Curr Price Prev. Close Change% W's Low/High

ADS Diagnostic Ltd.

11.34 10.8 0
11.3411.34

Apollo Hospitals Enterprise Ltd.

969.75 966.3 0.36
956.851035.7

Aspira Pathlab & Diagnostics Ltd.

17.82 16.98 4.95
17.8217.82

Aster DM Healthcare Ltd.

0 0 0
176.25190.75

Birla Pacific Medspa Ltd.

0.28 0.27 0
0.270.28

CDR Health Care Ltd.

7.58 2.6 0
7.227.58

Chennai Meenakshi Multispeciality Hospital Ltd.

21.8 21.8 0
21.823.8
More
Parameter Mar-17(in ₹ Cr.)
Cash from operating activities 89.27
Cash from investing activities -39.65
Cash from financing activities -48.50
Net change in cash 1.11

Stock Held By Mutual Fund Schemes

Corporate Details

About Management

The Company was incorporated as Thyrocare Technologies Limited on January 28, 2000 at Mumbai as a public limited company under the Companies Act, 1956. the Company was issued a certificate of commencement of business from the RoC on March 7, 2000. Major events and milestones of the Company : 2000 -The Company was incorporated in the name and style of "Thyrocare Technologies Limited' and received a certificate for commencement of operations. 2001 -The Company received ISO 9001 certification. -The Company commenced commercial operations under the brand name 'Thyrocare' pursuant to the acquisition of business of TDPL and TBPL (which were incorporated in 1996). 2005 -The Company received NABL accreditation. 2006 -The Company issued certain fully convertible debentures aggregating to 250 million to BCCL. 2007 -The Company receives accreditation from the College of American Pathologists (CAP). 2010 -The Company issued certain compulsorily convertible debentures aggregating to 250 million to Agalia. Agalia also acquired certain Equity Shares aggregating to 1,250 million from the Promoters and certain other persons. -The Company launched wellness packages under the brand name "Aarogyam". 2011 -The Company migrated to "total laboratory automation system" installed by Siemens for efficient handling of increasing volumes. 2012 -NVP acquired certain Equity Shares aggregating to 1,200 million from certain entities. 2013 -EIF acquired certain Equity Shares from Agalia. -The Subsidiary commenced operations at the PET-CT centres at Navi Mumbai and conducted over 1,000 scans in the first year of operation. 2014 -The Company had installed, India's first and the world's longest track automation system for seamless sample movements from Siemens Limited. -The Company commissioned the operations in medical cyclotron facility in Navi Mumbai. -The Subsidiary commenced operations at the PET-CT centres in New Delhi and Hyderabad and the PET-CT centres at New Delhi conducted over 1,000 scans in the first year of operations. 2015 -The Company opened RPLs in Delhi, Coimbatore, Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily. -The Company acquired the equipment for testing of water samples and commenced operating the equipment under the brand name "WHATERS". These tests, at present include physical and chemical testing, elements testing, microbiology testing, pesticide testing and volatile organic compounds testing. -The Subsidiary has completed over 10,000 scans at the PET-CT centres in New Delhi, over 10,000 scans at the PET-CT centres in Navi Mumbai from the date of inception and over 1,000 scans at the PET-CT centres in Hyderabad since inception. 2016 -Thyrocare Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities.

Registered Office

D/37-3, TTC Industrial Area, MIDC Turbhe,

,,,      ,

Registrar Details

Link Intime India Pvt. Ltd.